SOPHiA GENETICS SA (SOPH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.73, -7.68% vs the prior close of $7.29.
- Volume 915.44K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SOPH slides 7.7% to $6.73, a 1-month low. Closed at $6.73, -7.68% vs the prior close of $7.29. Day range $6.72–$7.48, opened at $7.48.
SOPH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SOPH slides 7.7% to $6.73, a 1-month low
- Closed at $6.73, -7.68% vs the prior close of $7.29. Day range $6.72–$7.48, opened at $7.48.
- Volume was 915.44K shares, 1.5x its 50-day average of 623.52K.
- Price is -15.3% vs its 50-day average ($7.95) and +15.5% vs its 200-day average ($5.83).
- 52-week range $3.75–$8.98; today's close sits at 57% of that range, 25.1% below the 52-week high.
Oct 15, 2026 — SOPH jumps 3.3% to $7.29 on 2.9x normal volume
- Closed at $7.29, +3.26% vs the prior close of $7.06. Day range $6.83–$7.44, opened at $7.00.
- Volume was 1.75M shares, 2.9x its 50-day average of 602.87K — unusually heavy trading.
- Price is -8.3% vs its 50-day average ($7.95) and +25.3% vs its 200-day average ($5.82).
- 52-week range $3.75–$8.98; today's close sits at 68% of that range, 18.8% below the 52-week high.
Oct 14, 2026 — SOPH dips 0.4% to $7.06, a 1-month low, 3 down days in a row
- Closed at $7.06, -0.42% vs the prior close of $7.09. Day range $7.01–$7.20, opened at $7.06.
- Volume was 377.20K shares, 0.6x its 50-day average of 627.87K.
- Price is -11.0% vs its 50-day average ($7.93) and +21.6% vs its 200-day average ($5.81).
- 52-week range $3.75–$8.98; today's close sits at 63% of that range, 21.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — SOPH dips 1.8% to $7.09, a 1-month low
- Closed at $7.09, -1.80% vs the prior close of $7.22. Day range $7.05–$7.32, opened at $7.20.
- Volume was 271.20K shares, 0.4x its 50-day average of 629.78K — lighter than usual.
- Price is -10.5% vs its 50-day average ($7.92) and +22.4% vs its 200-day average ($5.79).
- 52-week range $3.75–$8.98; today's close sits at 64% of that range, 21.0% below the 52-week high.
Oct 12, 2026 — SOPH dips 2.6% to $7.22
- Closed at $7.22, -2.56% vs the prior close of $7.41. Day range $7.01–$7.69, opened at $7.44.
- Volume was 478.90K shares, 0.8x its 50-day average of 621.76K.
- Price is -8.6% vs its 50-day average ($7.90) and +24.9% vs its 200-day average ($5.78).
- 52-week range $3.75–$8.98; today's close sits at 66% of that range, 19.6% below the 52-week high.
Oct 9, 2026 — SOPH rises 1.5% to $7.41
- Closed at $7.41, +1.51% vs the prior close of $7.30. Day range $7.07–$7.46, opened at $7.32.
- Volume was 328.10K shares, 0.5x its 50-day average of 618.85K — lighter than usual.
- Price is -5.8% vs its 50-day average ($7.87) and +28.4% vs its 200-day average ($5.77).
- 52-week range $3.75–$8.98; today's close sits at 70% of that range, 17.5% below the 52-week high.
Oct 8, 2026 — SOPH rises 2.1% to $7.30
- Closed at $7.30, +2.10% vs the prior close of $7.15. Day range $6.84–$7.40, opened at $7.15.
- Volume was 499.90K shares, 0.8x its 50-day average of 612.01K.
- Price is -6.8% vs its 50-day average ($7.83) and +26.8% vs its 200-day average ($5.76).
- 52-week range $3.75–$8.98; today's close sits at 68% of that range, 18.7% below the 52-week high.
Oct 7, 2026 — SOPH slides 3.1% to $7.15, a 1-month low
- Closed at $7.15, -3.12% vs the prior close of $7.38. Day range $7.08–$7.37, opened at $7.26.
- Volume was 432.80K shares, 0.7x its 50-day average of 606.45K.
- Price is -8.3% vs its 50-day average ($7.80) and +24.5% vs its 200-day average ($5.74).
- 52-week range $3.75–$8.98; today's close sits at 65% of that range, 20.4% below the 52-week high.
Oct 6, 2026 — SOPH slides 10.0% to $7.38, a 1-month low
- Closed at $7.38, -10.00% vs the prior close of $8.20. Day range $7.34–$8.56, opened at $8.40.
- Volume was 926.60K shares, 1.6x its 50-day average of 592.94K.
- Price is -5.0% vs its 50-day average ($7.77) and +28.8% vs its 200-day average ($5.73).
- 52-week range $3.75–$8.98; today's close sits at 69% of that range, 17.8% below the 52-week high.
Oct 5, 2026 — SOPH rises 1.6% to $8.20 on 2.1x normal volume
- Closed at $8.20, +1.61% vs the prior close of $8.07. Day range $7.90–$8.34, opened at $8.10.
- Volume was 1.18M shares, 2.1x its 50-day average of 573.16K — unusually heavy trading.
- Price is +6.1% vs its 50-day average ($7.73) and +43.4% vs its 200-day average ($5.72).
- 52-week range $3.75–$8.98; today's close sits at 85% of that range, 8.7% below the 52-week high.
Oct 2, 2026 — SOPH rises 0.5% to $8.07
- Closed at $8.07, +0.50% vs the prior close of $8.03. Day range $7.93–$8.38, opened at $8.10.
- Volume was 748.00K shares, 1.3x its 50-day average of 566.04K.
- Price is +5.0% vs its 50-day average ($7.68) and +41.6% vs its 200-day average ($5.70).
- 52-week range $3.75–$8.98; today's close sits at 83% of that range, 10.1% below the 52-week high.
SOPH latest news & SEC filings
Every SEC filing by or about SOPH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Menu Philippe sold 5,000 shares at $7.26 (≈$36.30K) on Oct 12, 2026; now holds 195,993
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Xu Zhenyu sold 4,000 shares at $7.18 (≈$28.73K) on Oct 13, 2026; now holds 541,493
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Camblong Jurgi sold 8,500 shares at $7.26 (≈$61.67K) on Oct 12, 2026; now holds 3,387,150
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Van Well Daan sold 6,168 shares at $8.12 (≈$50.10K) on Oct 5, 2026; now holds 332,716
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Valente Manuela sold 4,240 shares at $8.13 (≈$34.49K) on Oct 5, 2026; now holds 206,210
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Verma Abhimanyu sold 5,284 shares at $8.12 (≈$42.93K) on Oct 5, 2026; now holds 166,887
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade SOPH
- How much it moves: over the last 20 sessions the average daily move was 2.49% (largest 10.0%).
- Liquidity: about 622.80K shares (≈$4.19M) trade per day on average.
- 52-week position: $6.73 vs a range of $3.75–$8.98 (57% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Ross Muken sold 422 shares on Sep 21, 2026.
- Latest filings: 6-K Aug 4, 2026; 6-K Jun 22, 2026; 6-K Jun 22, 2026.
- Listing: Nasdaq · industry: Services-Computer Processing & Data Preparation.
SOPH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.48 | 7.48 | 6.72 | 6.73 | 915.44K |
| Oct 15, 2026 | 7.00 | 7.44 | 6.83 | 7.29 | 1.75M |
| Oct 14, 2026 | 7.06 | 7.20 | 7.01 | 7.06 | 377.20K |
| Oct 13, 2026 | 7.20 | 7.32 | 7.05 | 7.09 | 271.20K |
| Oct 12, 2026 | 7.44 | 7.69 | 7.01 | 7.22 | 478.90K |
| Oct 9, 2026 | 7.32 | 7.46 | 7.07 | 7.41 | 328.10K |
| Oct 8, 2026 | 7.15 | 7.40 | 6.84 | 7.30 | 499.90K |
| Oct 7, 2026 | 7.26 | 7.37 | 7.08 | 7.15 | 432.80K |
| Oct 6, 2026 | 8.40 | 8.56 | 7.34 | 7.38 | 926.60K |
| Oct 5, 2026 | 8.10 | 8.34 | 7.90 | 8.20 | 1.18M |
| Oct 2, 2026 | 8.10 | 8.38 | 7.93 | 8.07 | 748.00K |
| Oct 1, 2026 | 8.50 | 8.50 | 7.91 | 8.03 | 700.80K |
| Sep 30, 2026 | 8.48 | 8.67 | 8.28 | 8.38 | 471.20K |
| Sep 29, 2026 | 8.50 | 8.59 | 8.14 | 8.30 | 314.90K |
| Sep 28, 2026 | 8.33 | 8.73 | 8.10 | 8.49 | 547.70K |
| Sep 25, 2026 | 8.35 | 8.51 | 8.23 | 8.34 | 516.70K |
| Sep 24, 2026 | 8.08 | 8.31 | 7.89 | 8.26 | 426.40K |
| Sep 23, 2026 | 8.00 | 8.18 | 7.93 | 8.08 | 563.00K |
| Sep 22, 2026 | 8.25 | 8.51 | 8.04 | 8.07 | 570.80K |
| Sep 21, 2026 | 8.33 | 8.33 | 7.92 | 8.24 | 430.10K |
About SOPHiA GENETICS SA
SOPHiA GENETICS SA (SOPH) is listed on the Nasdaq and classified by the SEC under “Services-Computer Processing & Data Preparation”. Its business address is in ROLLE, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1840706.
SOPH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Tomer Berkovitz | Director | Mar 18, 2026 |
| Jurgi Camblong | Executive Chairman | Sep 14, 2026 |
| Jean-Michel Cossery | Director | Jun 22, 2026 |
| Troy Cox | Director | Jun 22, 2026 |
| Kathy L Hibbs | Director | Sep 10, 2026 |
| Didier Hirsch | Director | Jun 22, 2026 |
| Ross Muken | Chief Executive Officer | Sep 22, 2026 |
| Vincent Ossipow | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| George Cardoza | Chief Financial Officer | Sep 22, 2026 |
| Jurgi Camblong | Executive Chairman | Sep 14, 2026 |
| Philippe Menu | Chief Medical Officer | Sep 16, 2026 |
| Ross Muken | Chief Executive Officer | Sep 22, 2026 |
| Kevin Puylaert | Chief Sales Officer | Jul 7, 2026 |
| Manuela Valente | Chief People Officer | Aug 21, 2026 |
| Well Daan Van | Chief Legal Officer | Sep 14, 2026 |
| Abhimanyu Verma | Chief Technology Officer | Aug 26, 2026 |
| Zhenyu Xu | Chief Scientific Officer | Sep 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 21, 2026 | Ross Muken | Sale | 422 | $8.33 |
| Sep 21, 2026 | Ross Muken | Sale | 422 | $8.33 |
| Sep 21, 2026 | Ross Muken | Sale | 422 | $8.33 |
| Sep 21, 2026 | Ross Muken | Sale | 422 | $8.33 |
| Sep 21, 2026 | George Cardoza | Sale | 774 | $8.33 |
| Sep 21, 2026 | George Cardoza | Sale | 774 | $8.33 |
| Sep 21, 2026 | George Cardoza | Sale | 774 | $8.33 |
| Sep 21, 2026 | George Cardoza | Sale | 774 | $8.33 |
| Sep 14, 2026 | Philippe Menu | Sale | 5,000 | $7.88 |
| Sep 14, 2026 | Philippe Menu | Sale | 5,000 | $7.88 |
| Sep 14, 2026 | Philippe Menu | Sale | 5,000 | $7.88 |
| Sep 14, 2026 | Philippe Menu | Sale | 5,000 | $7.88 |
| Sep 14, 2026 | Zhenyu Xu | Sale | 4,000 | $7.88 |
| Sep 14, 2026 | Zhenyu Xu | Sale | 4,000 | $7.88 |
| Sep 14, 2026 | Zhenyu Xu | Sale | 4,000 | $7.88 |
SOPH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
SOPH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Computer Processing & Data Preparation
Reddit (RDDT)Applied Digital (APLD)Automatic Data Processing (ADP)Workday (WDAY)Toast (TOST)D-Wave Quantum (QBTS)Verisk Analytics (VRSK)Hinge Health (HNGE)RingCentral (RNG)Innodata (INOD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SOPH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.